EUVIMEDEUVIMED entdecken
Open Access

Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives

Milica Z Stevanović iD, Sofija S Bekić iD, Edward T Petri iD, Andjelka S Ćelić iD, Dimitar S Jakimov iD, Marija N Sakač iD, Ivana Z Kuzminac iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2024-0039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Milica Z Stevanović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Molecular Docking Simulation, Cell Proliferation, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMolecular Docking SimulationCell ProliferationDrug Screening Assays, AntitumorHumansCell Line, TumorAldo-Keto Reductase Family 1 Member C3Structure-Activity RelationshipMolecular StructureReceptors, AndrogenAromataseEstrogen Receptor alpha

Stichwörter der Autor:innen

2-picolyl steroidsaldo-keto reductaseantiproliferative activityaromatasehormone receptorsin silico ADMEmolecular dockingpicolinylidene

Substanzen

Antineoplastic AgentsAldo-Keto Reductase Family 1 Member C3AKR1C3 protein, humanReceptors, AndrogenAromataseEstrogen Receptor alpha

Autor:innen und Institutionen

  • Department of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.
  • Department of Biology & Ecology, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia.
  • Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Put Dr Goldmana 4, 21204 Sremska Kamenica, Serbia.

ORCID-Profile: Milica Z Stevanović, Sofija S Bekić, Edward T Petri, Andjelka S Ćelić, Dimitar S Jakimov, Marija N Sakač, Ivana Z Kuzminac

Förderung

  • the Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina

Zitieren

APA

Stevanović, M. Z., Bekić, S. S., Petri, E. T., Ćelić, A. S., Jakimov, D. S., Sakač, M. N., & Kuzminac, I. Z. (2024). Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2024-0039

Vancouver

Stevanović MZ, Bekić SS, Petri ET, Ćelić AS, Jakimov DS, Sakač MN, et al. Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2024-0039

BibTeX
@article{Stevanovi2024,
  author = {Stevanović, Milica Z and Bekić, Sofija S and Petri, Edward T and Ćelić, Andjelka S and Jakimov, Dimitar S and Sakač, Marija N and Kuzminac, Ivana Z},
  title = {Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2024-0039}
}
Kostenlos starten →